Raymond James Maintains Outperform on Murphy USA, Raises Price Target to $300
Raymond James analyst Bobby Griffin maintains Murphy USA (NYSE:MUSA) with a Outperform and raises the price target from $270 to $300.
Analyst Ratings for Murphy USA
Analysts have provided the following ratings for Murphy USA (NYSE:MUSA) within the last quarter:
Stephens & Co. Maintains Overweight on Murphy USA, Raises Price Target to $300
Stephens & Co. analyst Ben Bienvenu maintains Murphy USA (NYSE:MUSA) with a Overweight and raises the price target from $290 to $300.
Benzinga’s Top Ratings Upgrades, Downgrades For May 25, 2022
Upgrades
Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.
Wells Fargo Initiates Coverage On Murphy USA with Equal-Weight Rating, Announces Price Target of $230
Wells Fargo analyst Edward Kelly initiates coverage on Murphy USA (NYSE:MUSA) with a Equal-Weight rating and announces Price Target of $230.
Insider Buying Remains Elevated For A Second Week $SBUX $UBER $RILY
In an unusually volatile week, we saw significant market weakness earlier in the week probably driven by forced selling and a relief rally in the end. Insiders once again stepped up their purchases to take advantage of prices, which in some cases are down anywhere from 50% to 90% from their peaks.
Murphy USA Q1 EPS $6.08 Up From $2.01 YoY, Sales $5.12B Beat $4.66B Estimate
Murphy USA (NYSE:MUSA) reported quarterly earnings of $6.08 per share. This is a 202.49 percent increase over earnings of $2.01 per share from the same period last year. The company reported quarterly sales of $5.12
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Murphy USA: Q4 Earnings Insights
Murphy USA (NYSE:MUSA) reported its Q4 earnings results on Wednesday, February 2, 2022 at 04:30 PM.
Here's what investors need to know about the announcement.